J07BA01 • inactivated tick-borne encephalitis vaccine • Antiinfectives for systemic use | Viral vaccines | Encephalitis vaccines
The inactivated tick-borne encephalitis (TBE) vaccine is used to prevent infections caused by the TBE virus, transmitted through the bite of infected ticks. The vaccine contains inactivated viruses, which stimulate the immune system to produce specific antibodies, providing protection against the disease.
The vaccine is administered intramuscularly, usually in three doses for primary immunization, followed by booster doses at regular intervals to maintain immunity. It is recommended for individuals living in or traveling to endemic areas, as well as those engaging in outdoor activities in high-risk regions.
Common side effects include pain at the injection site, mild fever, fatigue, and headache. In rare cases, severe allergic reactions may occur.
The inactivated TBE vaccine is an important preventive measure for reducing the risk of infection and protecting public health in affected regions.
Substance: inactivated tick-borne encephalitis vaccine
Date of last drug list: 01-07-2013
Commercial code: W13338006
Concentration: 1.5mcg / 0.5ml
Pharmaceutical form: injection suspension
Quantity: 10
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).